Steno Diabetes Center
Gentofte Municipality, 2840, Denmark
NCT Number: NCT02494557
Diabetic type 2 patients (DB2) has a higher prevalence of coronary artery disease (CAD) than non-diabetic persons. Presence of CAD results in murmurs arising from the filling of the arteries and can be detected by the CADScor System and can together with biological patient profile indicate the risk of presence of CAD in the patient. In the pilot study 100 asymptomatic DB2-patients examined with CADScor System and biomarkers will be compared with computed tomography (CT) cardiography and single-photon emission computed tomography (SPECT) for assessing if combination of patient profile (gender, age etc) combined with above measures may give rise to new improved risk scoring method for he DB2-patient.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Observational
Gentofte Municipality, 2840, Denmark
The study is intended as a pilot observational study for evaluation of a new risk scoring method, CADScor System, is relevant for assessment of CAD in the DB2-patient.
The primary end point will be to document that the hypothesis of combining the CADScor System measure with other patient profile data will increase the accuracy of the method for determination of risk of presence of CAD.
The secondary endpoint will be to show that a receiver operating characteristic curve (ROC) of > 80% for correct determination of presence of CAD will be achieved.
The further objective of the study will be to confirm the relevance of performing a large scale study with equivalent objectives.
As controls in the study will be applied CT angiography, CT-calcium and resting and drug induced CT-scintigraphy.
It is assumed that 15-20 of enrolled patients in the study will suffer from CAD.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Comparison of an non-invasive acoustic Cad-score as risk prediction for presence of coronary artery disease with control studies of CT-angiography and resting and drug induced CT scintigraphy
Time frame: 1 year
Resting and drug induced perfusion test will be compared to CT Angiography for determining the degree of presence of CAD when including patient parameters characterizing the status and severity of the DB2.
Acarix
Industry
Acronym: CAD-risk
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06299735
Arterial Occlusive Diseases, Arteriosclerosis
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT01777503
Acute Coronary Syndrome, Arterial Occlusive Diseases
Reggio Emilia, Italy
View Trial DetailsNCT00129038
Arterial Occlusive Diseases, Arteriosclerosis
Dublin, Ireland
View Trial DetailsNCT00357955
Arterial Occlusive Diseases, Arteriosclerosis
Providence, Rhode Island, United States
View Trial Details